Emergency Drug Release Programme. A participant's doctor may ask the Bureau of Human Prescription Drugs of Health Canada for the release of an experimental drug on an emergency basis, if the drug manufacturer has authorized its release. The programme applies to new drugs not yet marketable and drugs currently used in clinical trials, as well as drugs approved for use in other countries, but not yet in Canada.